Baheal Pharmaceutical Group Enters Commercialization Partnership with Guangdong Ruidio Technology
China-based health services and distribution giant Baheal Pharmaceutical Group has struck a commercialization partnership with...
Deals
University of Hong Kong to Host Infectious Disease Labs by UN’s Vaccine Institute and Cambridge University
The University of Hong Kong (HKU) is poised to host new infectious disease laboratories established...
Jiangxi Rimag Group Eyes Hong Kong IPO to Expand Medical Imaging Services
Jiangxi Rimag Group Co., Ltd (HKG: 2522), a China-based medical imaging specialist, is planning an...
Q32 Bio Reclaims Development Rights to Anti-IL-7Rα Biologic from Amgen
Biotechnology firm Q32 Bio has announced its decision to reclaim full development and commercial rights...
Daewoong Pharma and Meheco International Expand Partnership for China’s Market Entry
Daewoong Pharma (KRX: 069620), a leading South Korean pharmaceutical company, has reportedly signed a memorandum...
Gilead’s Kite Expands Partnership with Arcellx for Innovative Cell Therapies
Gilead (NASDAQ: GILD), a leading biopharmaceutical company, has announced an expansion of its 2022 partnership...
AbbVie Partners with Sinopharm to Enhance Novel Drug Accessibility and Patient Management
US pharmaceutical giant AbbVie (NYSE: ABBV) has entered into a strategic partnership with Sinopharm Group...
Astellas Pharma Acquires Propella Therapeutics for $175 Million to Boost Prostate Cancer Treatment
Japan’s Astellas Pharma (TYO: 4503) has announced the negotiation of a purchase agreement for US...
Novartis Acquires HDAC6 Inhibitor CKD-510 from CKD Pharmaceutical in a $1.31 Billion Deal
Swiss pharmaceutical major Novartis (NYSE: NVS) announced last week that it has struck a deal...
Eli Lilly Clears Final Regulatory Hurdle with NRC Approval for Point Biopharma Acquisition
The Nuclear Regulatory Commission (NRC) of the US has given its approval for the transfer...
Hubei Topgene Biotechnology and Shanghai Genechem Partner on Drug Toxicological Safety and Clinical Research
Hubei Topgene Biotechnology Co., Ltd, a China-based biotechnology company, has entered into a partnership with...
PRECEDO Secures Over RMB 100 Million in Financing to Build Living Primary Cancer Cell Bank
PRECEDO, a leading cell engineering specialist headquartered in Hefei, has reportedly secured more than RMB...
Yantai Dongcheng Pharmaceutical and Eckert & Ziegler Form Joint Venture for Medical Isotopes
Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675), a China-based pharmaceutical company, is poised to...
Huadong Medicine Co., Ltd Secures Partnership and Commercial Rights for Yuyan’s Botulinum Toxin
China-based Huadong Medicine Co., Ltd (SHE: 000963) has entered into an equity investment and partnership...
Zeiss Group and China’s Healthcare Cloud Collaborate on Ophthalmic Services in China
Germany-based Zeiss Group, a leader in optical systems and optoelectronic product manufacturing, has entered into...
Novartis Pharma AG Partners with Legend Biotech Corp. for CAR-T Therapies in $1.1 Billion Deal
China-based Legend Biotech Corp., (NASDAQ: LEGN) has secured a second multinational partnership for its chimeric...
Nona Biosciences Partners with GeneQuantum Healthcare to Advance Drug Conjugate Discovery
Nona Biosciences, a wholly owned subsidiary of Harbour BioMed (HKG: 2142), which operates across the...
Autobio Diagnostics Expands Strategic Partnership with Guorun Medical Supply Chain Services
China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with Guorun Medical...
Boehringer Ingelheim and Scottish Enterprise Co-Lead GBP 4.3M Seed Funding for Glox Therapeutics
Germany’s Boehringer Ingelheim, in collaboration with Scotland’s national economic development agency Scottish Enterprise, has co-led...
AnchorDx Medical Partners with DiaCarta for Global Molecular Diagnostics Development
AnchorDx Medical Co., Ltd, a specialist in methylation high-throughput sequencing based in China, has entered...